ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 180 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,392 | -99.8% | 153,719 | +36.5% | 0.14% | +41.6% |
| Q3 2022 | $12,033,000 | +25.4% | 112,607 | +3.2% | 0.10% | +27.8% |
| Q2 2022 | $9,593,000 | -2.2% | 109,087 | +21.9% | 0.08% | +11.3% |
| Q1 2022 | $9,806,000 | -1.3% | 89,477 | +2.3% | 0.07% | -2.7% |
| Q4 2021 | $9,933,000 | +1.0% | 87,450 | +28.5% | 0.07% | +23.7% |
| Q3 2021 | $9,839,000 | +14.3% | 68,039 | -5.9% | 0.06% | +15.7% |
| Q2 2021 | $8,606,000 | +47.8% | 72,271 | +63.9% | 0.05% | +45.7% |
| Q1 2021 | $5,823,000 | +25.2% | 44,091 | +52.3% | 0.04% | +16.7% |
| Q4 2020 | $4,651,000 | +73.1% | 28,948 | +72.1% | 0.03% | +50.0% |
| Q3 2020 | $2,687,000 | +24.0% | 16,823 | +10.6% | 0.02% | +17.6% |
| Q2 2020 | $2,167,000 | +18.8% | 15,206 | +8.0% | 0.02% | 0.0% |
| Q1 2020 | $1,824,000 | +464.7% | 14,083 | +483.9% | 0.02% | +750.0% |
| Q4 2019 | $323,000 | +29.7% | 2,412 | +1.9% | 0.00% | 0.0% |
| Q3 2019 | $249,000 | -10.1% | 2,367 | -3.8% | 0.00% | 0.0% |
| Q2 2019 | $277,000 | +0.7% | 2,460 | +7.8% | 0.00% | 0.0% |
| Q1 2019 | $275,000 | – | 2,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |